{"name":"Chiome Bioscience Inc.","slug":"chiome-bioscience-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"CBA-1205 Part 1","genericName":"CBA-1205 Part 1","slug":"cba-1205-part-1","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"CBA-1205 Part 1","genericName":"CBA-1205 Part 1","slug":"cba-1205-part-1","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiY0FVX3lxTE1tdlo4Sk5qa1RfNk9seDQ3ZmVQTjUwdGNMRnFueHA0VjNnNFhLbzRSX1phdE4wdjM4NWZBZTFZQVZPRkMyeHByQ2UyY2NmTVZFU1FpLXMwM2FFcHFsYkg3Sk9jcw?oc=5","date":"2025-03-18","type":"pipeline","source":"pharmaphorum","summary":"4th World ADC Asia Summit - pharmaphorum","headline":"4th World ADC Asia Summit","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxPNXNGWW1xNzU3SWJ2YS1DbUtXVEF0enpJeXg4Q2lLQlo4Mi1CODhVVURjZDFFYmNvUUlmUUFXbmIwSjNXYWlxNk1TSDFkQ3B0MW5vUWVIWVpKZHRqd1B0Tk5MS2tXcE9vdkJtRWpFcmpIdk5uZk9GQ3VCYmoyemRsQXdBU0ZJZ18xblFmVm1WUEZzRk81V2NpLW01YXVZYWdYRGVCUWZYSzZRdWNlTVYwX3FkSmUwelVucXJoeW4yLUNpRkU0WkE?oc=5","date":"2024-12-12","type":"deal","source":"BioPharma APAC","summary":"Asahi Kasei Pharma Expands Global Reach with Exclusive Anti-CX3CR1 Antibody License - BioPharma APAC","headline":"Asahi Kasei Pharma Expands Global Reach with Exclusive Anti-CX3CR1 Antibody License","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7wFBVV95cUxOLU5EY3M3NU1aZ3c1QWpPZ2RzUW5vQ1pzNWF4WVpnZlAxeGhzVldtMV9jbE5MVHd4STdJeXlpc051VzdLckRDd2pqaDk4QnVNd0k0Q0lwWjBJdHJkd3p3UkJ6eWZCWThsajFRUTZzcmJYU1BYTUZQODdtUWt3WWdfZDV3NEtmYzg3SF9DMTgxYk5DMWpjUHNUSmJmeXBmdUJmSXNzMnRHcndXSDlvU1M0NnhvMHQ5THdMcGpiX3otWDZjdGJkYVdfVFhremNRaU5fXzdTd092cmZjM1VsRHVMMzNpQ3VLajd6bHFvd3d3VQ?oc=5","date":"2024-12-11","type":"deal","source":"Business Wire","summary":"Asahi Kasei Pharma Strengthens Global Reach with Exclusive License Agreement for anti-CX3CR1 Antibody - Business Wire","headline":"Asahi Kasei Pharma Strengthens Global Reach with Exclusive License Agreement for anti-CX3CR1 Antibody","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8gJBVV95cUxNZ3RHdzZ6eU1wZVV0N29Ja2kzQlAxVW5IVUh0aXFfc29YWUVtRjU3ZmJWM1N4LXZfazZZc05ZUnpDM1otUGNXX21Ta1VqSHFnQnQ2emUyVEstejBrWGVXZTlRWjl3X3lhX0IydUhCSHJMQW9fTVVtT0hlREtzVzN3N1dqOUNsN1hFZkJYekktcHlicUF6OXl4N2dmTUs3d05NRHViZlBSMHVkMDMwMzRDUWpqZE5HbzRhaDdxSGdROFZPTEhweEd1VXA3UUlhS3J4OFhxZUJMamNMUmx2TXVvTFRRb3gtZzM0LTRjVDNjVVV4ZTdMMTJFTnN1Rzg1UlNOSXN3YmdqU2hwOHhPN3hkQWhZdXdfdlhOWUpBeVdOaHA5SDBsNk4yRl9HY0hmNVN5WnhLdUJNUE40bmd2WkJ3YVktdkI4MmJRQmxqcHlWdkRqa1d4X2xnRDQtY3k2OWJ3MzJsMFVfcHN1clJrR2dFTm13?oc=5","date":"2024-06-25","type":"deal","source":"Business Wire","summary":"Monoclonal Antibody Collaboration and Licensing Deals Trends Report 2024 with Directory of 974 Partnering Deals Signed by the World's Leading Life Science Companies Since 2016 - ResearchAndMarkets.com","headline":"Monoclonal Antibody Collaboration and Licensing Deals Trends Report 2024 with Directory of 974 Partnering Deals Signed b","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNdHYyNlowSWtjRG51dnVjcGhLcy1RQkw3NVZGYWs4TkhHYUJMVTZ1SmRCSHBYUzFNUkNoT3NwbW91bUhvRFNFSmFzTFdrZDdiWEZkUldQbUM4eldNMkc4MlRxWUtDbVFSd2k1UklZMTZicXJ4ZFJ3YzU2cnhMNEExMTFwWWx6Y1JNS0hlNWE2TzdYUi1m?oc=5","date":"2021-01-18","type":"deal","source":"The Pharma Letter","summary":"Chiome and Henlius in oncology licensing deal - The Pharma Letter","headline":"Chiome and Henlius in oncology licensing deal","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}